Clinical trial NCT05525377: Better Living With Non-memory-led Dementia
Official title: Better Living With Non-memory-led Dementia: Feasibility Study on the Effects of a Blended Online Training Course for Carers of People With Atypical AD and FTD.
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Primary Progressive Aphasia
Frontotemporal Dementia
Alzheimer Disease
Keywords: "Posterior Cortical Atrophy"
Lead sponsor: University College, London
Sponsor class: OTHER
First posted: 2022-09-01
Enrollment: 31
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: This is a feasibility study on the effects of an online-based training and education programme for carers of people with posterior cortical atrophy (PCA), primary progressive aphasia (PPA) and behavioural-variant frontotemporal dementia (bvFTD).

Detailed description: The purpose of this study is:

To evaluate the feasibility of an online training course for carers of people with PCA, PPA, and bvFTD. Feasibility measures will focus on the recruitment process and measurement tools.

To determine the acceptability of an online training course for carers of people with PCA, PPA and bvFTD.

The study will involve 6 online modules over the course of 7 weeks. All sessions will take place over the internet, using an online platform. A research team member (facilitator) will be available to assist participants over the course completion.

Eligibility criteria: Inclusion Criteria:

1. . Adults (18+) who self-identify as an unpaid carer (partners, children, friends, etc.) of someone with PPA, PCA or bvFTD who is not living in a full-time care facility.
2. . The care recipient has to have a confirmed diagnosis of dementia (through self-report of the carer, to reflect the 'real world' application of the intervention).

Exclusion Criteria:

1. . Those unable to comprehend written English
2. . Those with no access to the internet

Primary outcomes:
measure: Study feasibility
timeFrame: Since June 2022 to January 2023 (8 months)
measure: Acceptability
timeFrame: Since June 2022 to January 2023 (8 months)
Secondary outcomes:
measure: WHO 5 Wellbeing Index
timeFrame: Change from baseline to 8 weeks and 3 months
measure: Generalized Anxiety Disorder scale (GAD-7)
timeFrame: Change from baseline to 8 weeks and 3 months
measure: Patient Health Questionnaire (PHQ-9)
timeFrame: Change from baseline to 8 weeks and 3 months
measure: De Jong Gierveld Loneliness Scale
timeFrame: Change from baseline to 8 weeks and 3 months
measure: Lubben Social Network Scale
timeFrame: Change from baseline to 8 weeks and 3 months
measure: Pearling Mastery Scale
timeFrame: Change from baseline to 8 weeks and 3 months
measure: Caregiver self-efficacy scale
timeFrame: Change from baseline to 8 weeks and 3 months
measure: Dementia Management Strategies Scale
timeFrame: Change from baseline to 8 weeks and 3 months
measure: The quality of carer-partner relationship scale
timeFrame: Change from baseline to 8 weeks and 3 months
measure: Questions about perceived burden and ethicality
timeFrame: At 8 weeks post-randomisation and 3 month follow up
measure: Health economics questions
timeFrame: At 8 weeks post-randomisation and 3 month follow up
Other outcomes:
Locations:
city: London
country: United Kingdom
facility: University College London
Study officials:
References: